Source news

dow-jones News

20 stories
dow-jones

Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion — Update

By Adria CalatayudIpsen said it agreed to buy Kartos Therapeutics in a deal valued at up to $1.75 billion that seeks to strengthen the French drugmaker's pipeline of cancer medicines.Through the acquisition, Ipsen adds a late-stage drug candidate for myelofibrosis--a rare blood cancer--to expand it…

Dow Jones Newswires en
StocksFR
NEWS dow-jones

U.S. Political, Economic Calendar - Week Ahead

All dates are in ET Time. Monday, June 29, 2026 Exp Prev ET/GMT 1030/1430 Jun Texas Manufacturing Outlook Survey Business Activity 0.4 Mfg Production Idx…

Dow Jones Newswires en
Economy

Earnings Forecasts Are on Steroids — WSJ

By Spencer JakabDo we have an all-clear? The S&P 500 and Nasdaq composite indexes fell every single session last week, mainly on AI worries, but they appear set to start a holiday-shortened one with gains. Oil prices are higher too overnight after more skirmishing in the Middle East. The U.S. andIr…

Dow Jones Newswires en
index
NEWS dow-jones

Dollar Could Fall if Fed Leaves Rates on Hold — Market Talk

1026 GMT - The dollar could weaken by year-end as the Federal Reserve probably won't raise interest rates as markets anticipate, MUFG Bank analysts say in a note. New Fed Chairman Kevin Warsh's tough rhetoric on inflation fueled bets the Fed could lift rates. However, the Fed is likely to keep rate…

Dow Jones Newswires en
BondsForex
dow-jones

Dollar Could Fall if Fed Leaves Rates on Hold — Market Talk

The dollar could weaken by year-end as the Federal Reserve probably won't raise interest rates as markets anticipate, MUFG Bank analysts say in a note. New Fed Chairman Kevin Warsh's tough rhetoric on inflation fueled bets the Fed could lift rates. However, the Fed is likely to keep rates on hold…

Dow Jones Newswires en
Forex
dow-jones

AbbVie Gets CHMP Backing for Rinvoq in Vitiligo, Alopecia Areata

By Colin KellaherAbbVie said a key European regulatory committee has recommended expanded approval of its blockbuster autoimmune drug Rinvoq in the autoimmune diseases vitiligo and alopecia areata.AbbVie on Monday said the positive opinions from the European Medicines Agency's Committee for Medicin…

Dow Jones Newswires en
StocksUS